This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Olanzapine and Blepharoclonus

Caroline Klaus Sofia-Gabrion, MA; Yacine Ali Yahia, MD; and Laurent Holzer, MD

Published: September 17, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Olanzapine is an atypical neuroleptic associated with low risk of extrapyramidal symptoms (EPS).1 However, recent case reports2-4 suggest that some patients developed abnormal movements while taking olanzapine. Incidence of motor eyelid complications associated with atypical antipsychotics is uncommon, and only a few case reports of blepharospasm or Meige’s syndrome have been reported with risperidone and olanzapine.4‘ ‹’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 68

Quick Links: Schizophrenia and Schizoaffective Disorders , Side Effects

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...